StentBoost Visualization for the Evaluation of Coronary Stent Expansion During Percutaneous Coronary Interventions [0.03%]
冠脉造影图像中评估经皮冠状动脉介入治疗过程中支架展开情况的血管可视化方法研究
Fernando Cura,Mariano Albertal,Alfonsina Candiello et al.
Fernando Cura et al.
Introduction: Inadequate stent implantation is associated with stent thrombosis and restenosis. StentBoost can enhance stent visualization and evaluate stent expansion. Currently, there are limited comparison studies betw...
Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks [0.03%]
不同卒中风险的房颤患者口服抗凝药与华法林的治疗费用比较
Steve Deitelzweig,Alpesh Amin,Yonghua Jing et al.
Steve Deitelzweig et al.
Introduction: The Apixaban for the Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE), Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY), and Rivaroxaban Once Daily Ora...
Coronary angiography utilization and costs for coronary artery bypass graft surgery patients in Turkey [0.03%]
土耳其冠状动脉旁路移植术患者的冠状动脉造影使用率和费用
Onur Baser,Abdulkadir Burkan,Erdem Baser et al.
Onur Baser et al.
Introduction: To assess excess use of coronary angiography prior to coronary artery bypass graft surgery and its association with mortality, health care costs, and hospital quality in Turkey. ...
Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants [0.03%]
新型口服抗凝药物在≥75岁房颤患者中的应用：老年患者抗凝治疗策略的改变
Kuan H Ng,Robert G Hart,John W Eikelboom
Kuan H Ng
Atrial fibrillation (AF) is an important cause of preventable, disabling stroke and is increasingly prevalent with advancing age. As life expectancies increase around the world, AF-related stroke is a growing global public health concern. M...
Dylan L Steen,Michelle L O&#x;Donoghue
Dylan L Steen
Evidence suggests that inflammation plays a central role in the pathogenesis of atherosclerosis (Libby, Nature 420:868-874, 2002). Inflammation is a physiologic process with highly regulated and often redundant mechanisms to balance pro-inf...
Amy Sarma,Jeffrey E Rossi,Jean M Connors et al.
Amy Sarma et al.
Introduction: Novel oral anticoagulants are increasingly used for stroke prophylaxis in patients with non-valvular atrial fibrillation. While these agents offer a more predictable pharmacokinetic profile, the lack of read...
An extremely rare combination: pneumopericardium, pneumoperitoneum, and subcutanous emphysema-a case report [0.03%]
罕见的气胸、纵隔气肿和皮下气肿三联征病例报道
Melek Zekiye Uluçam
Melek Zekiye Uluçam
Pneumopericardium, an accumulation of air in the pericardial cavity, occurs very rarely as compared to pneumothorax and pneumomediastinum. Clinical presentation is variable, patients are frequently asymptomatic, and mild cases usually resol...
Fenestrated atrial septal defect percutaneously occluded by a single device: procedural and financial considerations [0.03%]
房间隔缺损的经皮封堵术的操作和花费考虑因素——用一种装置封堵室间隔缺损带孔病例
Roie Tal,Qarawani Dahud,Avraham Lorber
Roie Tal
A 45-year-old patient presented with a cerebrovascular attack and was subsequently found to have a multi-fenestrated atrial septal defect. Various therapeutic options for percutaneous transcatheter closure with their respective benefits and...
Balancing antiplatelet and anticoagulant therapies in patients with cardiovascular disease [0.03%]
心血管病患者的抗血小板和抗凝治疗的平衡
Edward T Carreras,Jessica L Mega
Edward T Carreras
Anticoagulation is needed for stroke prevention in patients with atrial fibrillation. Antiplatelet therapy is essential for the prevention of stent thrombosis and the reduction of cardiovascular events in patients who undergo coronary stent...
Optimal choice of coronary revascularization and stent type in diabetic patients with coronary artery disease [0.03%]
糖尿病冠心病患者冠状动脉血运重建及支架类型的选择
Ralf E Harskamp,Duk-Woo Park
Ralf E Harskamp
Patients with diabetes mellitus (DM) are prone to a diffuse and accelerated form of coronary artery disease (CAD), which in turn is a major cause of cardiac-related morbidity and mortality. Compared with patients without diabetes, patients ...